News from SGC

Posted on Tuesday 2nd of May 2023

The University of Toronto's Acceleration Consortium has received a record-breaking $200 million Canada First Research Excellence Fund (CFREF) to advance the discovery of new materials and molecules. This award marks the largest single federal research grant to a university in Canadian history. 

Posted on Friday 16th of September 2022

December 4-7

Brisbane, Australia

Target 2035 will be featured at the ICBS Annual Conference on December 6. Don’t delay – submit your abstract by September 30.

For more information, visit ICBS2022.

 

Posted on Wednesday 3rd of August 2022

SGC CEO, Aled Edwards, and Cheryl Arrowsmith, Chief Scientist for the Structural Genomics Consortium (SGC) Toronto laboratories are featured in a piece by the Institute for Protein Innovation discussing Target 2035- a remarkable initiative connecting scientists globally in the quest to study every human protein by 2035.

Read the Institute for Protein Innovation article
 

Posted on Tuesday 5th of July 2022

Cheryl Arrowsmith, Chief Scientist for the Structural Genomics Consortium (SGC) Toronto laboratories, and Paul Workman, Professor of Pharmacology and Therapeutics at the Institute of Cancer Research (ICR) in London, talked to Nature Communications about chemical probes, their respective paths to leadership positions in the field, the online resources available to those interested in the topic and the promise and value of open — collaborative — science.

Posted on Monday 16th of May 2022

Toronto, May 16, 2022 – An article published today in the journal Nature Chemical Biology reveals a mechanism of antitumor activity for triple negative breast cancer, which is the most aggressive breast cancer subtype with less promising prognosis and with few effective therapies.

Posted on Tuesday 8th of March 2022

Toronto, March  8, 2022 - The Structural Genomics Consortium (SGC) is pleased to announce three new members of the open science consortium: Bristol Myers Squibb, Genentech, a member of the Roche Group, and Janssen Pharmaceutica NV.

Posted on Friday 25th of February 2022

Toronto, February 25, 2022 - The Structural Genomics Consortium (SGC) is excited to welcome the Montreal Neurological Institute-Hospital (The Neuro) at McGill University and Open Chemistry Networks (OCN) based at University College London (UCL) as its latest academic partners.

SGC is pleased to have The Neuro and UCL officially contribute to our academic network, adopting SGC’s “patent-free” open science model for their SGC-associated teams.

Posted on Tuesday 22nd of February 2022

 

Toronto, February 22, 2022 – The roadmap for CACHE, an open science benchmarking initiative to enable the development of computational methods for hit-finding, has been published in Nature Reviews Chemistry.

Posted on Monday 22nd of November 2021

Toronto, November 23, 2021 – The Structural Genomics Consortium (SGC) is pleased to announce a new research initiative, funded by The Michael J. Fox Foundation for Parkinson’s Research, focusing on the WD domain of LRRK2. Using computational methods, this initiative will explore complementary and novel therapeutic strategies to target LRRK2.

Pages

Subscribe to News from SGC
glqxz9283 sfy39587stf02 mnesdcuix8
sfy39587stf03